Zhou, J., Wu, R., High, A. A., Slaughter, C. A., Finkelstein, D., Rehg, J. E., . . . Häcker, H. (2011). A20-binding inhibitor of NF-κB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein β activation and protects from inflammatory disease. National Academy of Sciences.

Zhou, Jingran, Ruiqiong Wu, Anthony A. High, Clive A. Slaughter, David Finkelstein, Jerold E. Rehg, Vanessa Redecke, i Hans Häcker. A20-binding Inhibitor of NF-κB (ABIN1) Controls Toll-like Receptor-mediated CCAAT/enhancer-binding Protein β Activation and Protects From Inflammatory Disease. National Academy of Sciences, 2011.

Zhou, Jingran, et al. A20-binding Inhibitor of NF-κB (ABIN1) Controls Toll-like Receptor-mediated CCAAT/enhancer-binding Protein β Activation and Protects From Inflammatory Disease. National Academy of Sciences, 2011.